Successful Treatment ofEnterococcus faecalisProsthetic Valve Endocarditis with Linezolid
Open Access
- 1 October 2002
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 35 (7), 902-904
- https://doi.org/10.1086/342572
Abstract
Sir —Linezolid possesses a broad spectrum of activity against gram-positive organisms, including Enterococcus faecalis [1]. Like other agents used for the treatment of E. faecalis endocarditis, linezolid possesses only bacteriostatic activity [2].Keywords
This publication has 8 references indexed in Scilit:
- Linezolid and Reversible MyelosuppressionPublished by American Medical Association (AMA) ,2001
- Successful Treatment of Vancomycin-Resistant Enterococcus Endocarditis with Oral LinezolidClinical Infectious Diseases, 2001
- Linezolid and Reversible MyelosuppressionJAMA, 2001
- Linezolid Therapy of Vancomycin-Resistant Enterococcus faecium Experimental EndocarditisAntimicrobial Agents and Chemotherapy, 2001
- Use of Linezolid, an Oxazolidinone, in the Treatment of Multidrug-Resistant Gram-Positive Bacterial InfectionsClinical Infectious Diseases, 2000
- Comparative In Vitro and Bactericidal Activity of Oxazolidinone Antibiotics Against Multidrug-Resistant EnterococciDiagnostic Microbiology and Infectious Disease, 1998
- Prevention of Bacterial Endocarditis: Recommendations by the American Heart AssociationClinical Infectious Diseases, 1997
- Prevention of Bacterial EndocarditisJAMA, 1997